The global tissue engineered skin substitutes market segmentation is based on product types (acellular, cellular allogeneic, cellular autologous), and its applications (burn injury, diabetic, vascular ulcer).
According to a market research report Tissue Engineered Skin Substitutes Market 2017-2021 published by iHealthcareAnalyst, Inc., the global tissue engineered skin substitutes market is estimated to reach US$ 2.1 Billion in 2020, expanding at a CAGR of 16.0% from 2017 to 2021.
Visit the Tissue Engineered Skin Substitutes Market 2017-2021 report at https://www.ihealthcareanalyst.com/report/tissue-engineered-skin-substitutes-market/
The global tissue engineered skin substitutes market report provides market size (Revenue US$ Million 2014 to 2021), market share and forecasts growth trends (CAGR%, 2017 to 2021).
The global tissue engineered skin substitutes market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market. The global tissue engineered skin substitutes market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
- Product Type
- Cellular Allogeneic
- Cellular Autologous
- Burn Injury
- Diabetic, Vascular Ulcer
- Geography (Region, Country)
- North America (U.S., Canada)
- Latin America (Brazil, Mexico, Rest of LA)
- Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
- Asia Pacific (Japan, China, India, Rest of APAC)
- Rest of the World
- Company Profiles
- Acelity L.P., Inc.
- BSN Medical
- Integra LifeSciences Corporation
- Medtronic (Covidien)
- Mölnlycke Health Care
- Smith & Nephew plc
- Organogenesis, Inc
iHealthcareAnalyst, Inc. is a global health care market research and consulting company providing market analysis, and competitive intelligence services to global clients. The Company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
iHealthcareAnalyst, Inc. provides industry participants and stakeholders with strategically analyzed, unbiased view of market dynamics and business opportunities within its coverage areas.